49
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye

Pages 2129-2131 | Published online: 17 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Magdalena Edington, Julie Connolly & Ngaihang Victor Chong. (2017) Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes. Expert Opinion on Drug Metabolism & Toxicology 13:12, pages 1217-1224.
Read now

Articles from other publishers (3)

Setsuko Kawakami, Yoshihiro Wakabayashi, Kazuhiko Umazume, Yoshihiko Usui, Daisuke Muramatsu, Tsuyoshi Agawa, Kaori Yamamoto & Hiroshi Goto. (2021) Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration. Journal of Ophthalmology 2021, pages 1-8.
Crossref
Ursula Schmidt-Erfurth, José Garcia-Arumi, Bianca S. Gerendas, Edoardo Midena, Sobha Sivaprasad, Ramin Tadayoni, Sebastian Wolf & Anat Loewenstein. (2019) Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmologica 242:3, pages 123-162.
Crossref
Jesse J. Jung, Quan V. Hoang, Mohammad Z. Y. Arain & Stanley Chang. (2016) Aflibercept anti-vascular endothelial growth factor therapy in vitrectomized eyes with neovascular age-related macular degeneration. Acta Ophthalmologica 94:3, pages e249-e250.
Crossref